Thank you for subscribing!
Next Investors Oct 07, 2023
In this feature, we look at why some small cap share prices surge upwards despite bear market conditions. We also saw our 2021 Biotech Pick of the Year surge 200% in two days this week.
Next Investors Sep 29, 2023
Could we be on the cusp of a multi-year uranium bull market? We look into this question as well as some of the key drivers behind the recent run in the uranium price.
Next Investors Jun 27, 2022
Market mood swings. Down on low volumes, now up. What is price discovery? What is Enterprise Value? Current lowest Enterprise Values in our Portfolio. Cash is king. Current biggest cash balances in our Portfolio.
Next Investors Jun 11, 2022
Many small cap stocks (including our Portfolio stocks) have taken a downward hit on relatively small volume in June. And to put the boot into an already rougher than usual “sell in May and go away” and “tax loss selling June”...
Get expert stock analysis direct in your inbox
Next Investors Jun 06, 2022
Goldman on lithium. Movers in our portfolio. Is a bull market coming in the “real economy”? An expert presents on critical materials.
Next Investors Oct 13, 2020
Long term Creso Pharma (ASX: CPH) shareholders have had a rough ride in the last 12 months. Last week the $20M capped CPH raised circa A$9M at $0.0291 per share, finally extinguishing the company’s debt and ridding the company of major con note holders that were hampering any share price appreciation.
Finfeed Archived Apr 16, 2020
Don’t be lured into the ‘Bear Market Trap’ and perceived honey pot of gains to be had just because the market has risen like a soufflé in the past few weeks.
Finfeed Archived Feb 28, 2020
Companies have not changed their earnings forecast, which means they do not foresee any issues arising from the coronavirus. Given this, I see no reason to sell, as many of these companies will bounce back in the not too distant future.
Finfeed Archived Dec 18, 2019
This can be a period when markets swing wildly as evidenced by the performance of the Dow Jones index leading up to and following the election of Trump as president.’
Join Our Mailing List
